News for Healthier Living

New Ovarian Cancer Drug Can Affect the Eyes, Suggests First Real-World Study

The first real-world study on mirvetuximab ocular toxicity shows more than 55 percent of patients experienced decreased vision due to corneal damage.

October 17, 2024


October 19 2024

October 18 2024

October 17 2024

October 16 2024

October 15 2024

October 14 2024

October 13 2024

October 12 2024

October 11 2024

October 10 2024

October 9 2024

October 8 2024

October 7 2024

October 6 2024

October 5 2024